Literature DB >> 28878581

Optical Coherence Tomographic Evaluation of Hyperacute Bivalirudin-Induced Coronary Stent Thrombosis.

Jorge L Peñalver, Wassim Shatila, Emerson Perin.   

Abstract

Thrombus formation after stent deployment has been linked to the use of heparin and of antithrombotic agents, such as bivalirudin, during percutaneous coronary intervention. Fluoroscopy has been used to identify stent thrombosis, typically after patients become symptomatic. We describe our use of optical coherence tomography to diagnose and evaluate intraprocedural stent thrombosis in a 68-year-old man who was given bivalirudin just before a percutaneous coronary procedure. This imaging method enabled immediate therapeutic intervention.

Entities:  

Keywords:  Angioplasty, balloon, coronary/adverse effects; anticoagulants/adverse effects/therapeutic use; coronary thrombosis/diagnostic imaging/prevention & control; percutaneous coronary intervention/adverse effects; stents; time factors; tomography, optical coherence/therapeutic use; treatment outcome

Mesh：

Substances：

Year:  2017        PMID： 28878581      PMCID： PMC5577953          DOI： 10.14503/THIJ-16-6075

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


  8 in total

1.  Bivalirudin (Angiomax) use during intracoronary brachytherapy may predispose to acute closure.

Authors:  Sanjiv Sharma; Brijesh Bhambi; William Nyitray; Kirit Desai; Dean L Davis; Geetanjali Sharma; Pankaj Shukla; Carla File; Tetsuo Ishimori
Journal:  J Cardiovasc Pharmacol Ther       Date:  2003-03       Impact factor: 2.457

2.  Acute stent thrombosis: technical complication or inadequate antithrombotic therapy? An optical coherence tomography study.

Authors:  Sammy Elmariah; Ik-Kyung Jang
Journal:  JACC Cardiovasc Interv       Date:  2012-02       Impact factor: 11.195

3.  Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation.

Authors:  Guillermo J Tearney; Evelyn Regar; Takashi Akasaka; Tom Adriaenssens; Peter Barlis; Hiram G Bezerra; Brett Bouma; Nico Bruining; Jin-man Cho; Saqib Chowdhary; Marco A Costa; Ranil de Silva; Jouke Dijkstra; Carlo Di Mario; Darius Dudek; Darius Dudeck; Erling Falk; Erlin Falk; Marc D Feldman; Peter Fitzgerald; Hector M Garcia-Garcia; Hector Garcia; Nieves Gonzalo; Juan F Granada; Giulio Guagliumi; Niels R Holm; Yasuhiro Honda; Fumiaki Ikeno; Masanori Kawasaki; Janusz Kochman; Lukasz Koltowski; Takashi Kubo; Teruyoshi Kume; Hiroyuki Kyono; Cheung Chi Simon Lam; Guy Lamouche; David P Lee; Martin B Leon; Akiko Maehara; Olivia Manfrini; Gary S Mintz; Kyiouchi Mizuno; Marie-angéle Morel; Seemantini Nadkarni; Hiroyuki Okura; Hiromasa Otake; Arkadiusz Pietrasik; Francesco Prati; Lorenz Räber; Maria D Radu; Johannes Rieber; Maria Riga; Andrew Rollins; Mireille Rosenberg; Vasile Sirbu; Patrick W J C Serruys; Kenei Shimada; Toshiro Shinke; Junya Shite; Eliot Siegel; Shinjo Sonoda; Shinjo Sonada; Melissa Suter; Shigeho Takarada; Atsushi Tanaka; Mitsuyasu Terashima; Troels Thim; Thim Troels; Shiro Uemura; Giovanni J Ughi; Heleen M M van Beusekom; Antonius F W van der Steen; Gerrit-Anne van Es; Gerrit-Ann van Es; Gijs van Soest; Renu Virmani; Sergio Waxman; Neil J Weissman; Giora Weisz
Journal:  J Am Coll Cardiol       Date:  2012-03-20       Impact factor: 24.094

4.  Intracoronary macrothrombus formation during percutaneous coronary intervention despite optimal activated clotting time using bivalirudin--a case report.

Authors:  George M Tadros; Kevin Broder; Fouad Bachour
Journal:  Angiology       Date:  2005 Nov-Dec       Impact factor: 3.619

5.  Clinical end points in coronary stent trials: a case for standardized definitions.

Authors:  Donald E Cutlip; Stephan Windecker; Roxana Mehran; Ashley Boam; David J Cohen; Gerrit-Anne van Es; P Gabriel Steg; Marie-angèle Morel; Laura Mauri; Pascal Vranckx; Eugene McFadden; Alexandra Lansky; Martial Hamon; Mitchell W Krucoff; Patrick W Serruys
Journal:  Circulation       Date:  2007-05-01       Impact factor: 29.690

6.  Case report: a thrombus in the venous reservoir while using bivalirudin in a patient with heparin-induced thrombocytopenia undergoing heart transplantation.

Authors:  Jim K Wong; Ying Tian; Paul Shuttleworth; Anthony D Caffarelli; Bruce A Reitz; Christina T Mora-Mangano
Journal:  Anesth Analg       Date:  2010-08-04       Impact factor: 5.108

7.  Extensive fatal intracoronary thrombosis during percutaneous coronary intervention with bivalirudin.

Authors:  Sanjiv Sharma; Shirish Patel; Ashok Behl; Sarabjeet Singh; Rasham Sandhu; Neil Bhambi; Rohan Sharma; Brijesh Bhambi
Journal:  Am J Ther       Date:  2014 Jul-Aug       Impact factor: 2.688

8.  Intra-procedural stent thrombosis: a new risk factor for adverse outcomes in patients undergoing percutaneous coronary intervention for acute coronary syndromes.

Authors:  Sorin J Brener; Ecaterina Cristea; Ajay J Kirtane; Margaret B McEntegart; Ke Xu; Roxana Mehran; Gregg W Stone
Journal:  JACC Cardiovasc Interv       Date:  2012-12-19       Impact factor: 11.195
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.